Reauthorizing the ACT for ALS Press Conference

Video Description

On Wednesday, April 15, 2026, Chicago Congressman Mike Quigley (IL-05) will hold a press conference highlighting the bipartisan, bicameral Accelerating Access to Critical Therapies for ALS Reauthorization Act (ACT for ALS Reauthorization Act) of 2026, following the bill’s Energy & Commerce Hearing that morning. The ACT for ALS Reauthorization Act will renew a five-year program that advances ALS science and helps people living with ALS access promising treatments. The bill is led by Quigley and Congressman Ken Calvert (CA-41) in the House and Senators Lisa Murkowski (AK) and Chris Coons (DE) in the Senate. Speakers at this press conference include: Rep. Mike Quigley (IL-05) Rep. Morgan Griffith (VA-09), Chair of the Energy & Commerce Health Subcommittee I AM ALS founder and ALS Patient Advocate Brian Wallach and Founder and CEO of Synapticure Sandra Abrevaya I AM ALS Board Member and Patient Advocate Dan Tate President and CEO of the ALS Association Calaneet Balas President and CEO of the ALS Network Sheri Strahl Community Volunteer and Former Caregiver Garrett May Neurologist and ALS Researcher Dr. Jinsy Andrews #ALS #publichealth #bipartisanship